Previous Close | 0.0800 |
Open | 0.0950 |
Bid | 0.0000 x 0 |
Ask | 0.1000 x 0 |
Day's Range | 0.0800 - 0.0950 |
52 Week Range | 0.0400 - 0.1700 |
Volume | |
Avg. Volume | 4,295 |
Market Cap | 2.647M |
Beta (5Y Monthly) | 0.29 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1200 |
Earnings Date | Jun 03, 2024 - Jun 07, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
TORONTO, ON / ACCESSWIRE / March 13, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) - ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and ...
TORONTO, ON / ACCESSWIRE / March 6, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic ...
TORONTO, ON / ACCESSWIRE / February 26, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and ...